KLRK1 and neoplasm: The chimeric NKG2D receptor (chNKG2D) is a protein formed by the fusion of the NKG2D receptor and the CD3ζ chain, which gives T cells the ability to recognize tumor cells and mount an immune attack via NKG2D.